BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27567868)

  • 1. An Oral Aβ Vaccine Using a Recombinant Adeno-Associated Virus Vector in Aged Monkeys: Reduction in Plaque Amyloid and Increase in Aβ Oligomers.
    Hara H; Ono F; Nakamura S; Matsumoto SE; Jin H; Hattori N; Tabira T
    J Alzheimers Dis; 2016 Oct; 54(3):1047-1059. PubMed ID: 27567868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet.
    Lemere CA; Beierschmitt A; Iglesias M; Spooner ET; Bloom JK; Leverone JF; Zheng JB; Seabrook TJ; Louard D; Li D; Selkoe DJ; Palmour RM; Ervin FR
    Am J Pathol; 2004 Jul; 165(1):283-97. PubMed ID: 15215183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive immunization of aged and juvenile non-human primates to β-amyloid.
    Kofler J; Lopresti B; Janssen C; Trichel AM; Masliah E; Finn OJ; Salter RD; Murdoch GH; Mathis CA; Wiley CA
    J Neuroinflammation; 2012 May; 9():84. PubMed ID: 22554253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy is involved in oral rAAV/Aβ vaccine-induced Aβ clearance in APP/PS1 transgenic mice.
    Wang HC; Zhang T; Kuerban B; Jin YL; Le W; Hara H; Fan DS; Wang YJ; Tabira T; Chui DH
    Neurosci Bull; 2015 Aug; 31(4):491-504. PubMed ID: 26254061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains.
    Takahashi RH; Yokotsuka M; Tobiume M; Sato Y; Hasegawa H; Nagao T; Gouras GK
    Brain Pathol; 2021 Sep; 31(5):e12941. PubMed ID: 33624334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal immunotherapy in an Alzheimer mouse model by recombinant Sendai virus vector carrying Aβ1-43/IL-10 cDNA.
    Hara H; Mouri A; Yonemitsu Y; Nabeshima T; Tabira T
    Vaccine; 2011 Oct; 29(43):7474-82. PubMed ID: 21803105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model.
    Mouri A; Noda Y; Hara H; Mizoguchi H; Tabira T; Nabeshima T
    FASEB J; 2007 Jul; 21(9):2135-48. PubMed ID: 17341681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a safe oral Abeta vaccine using recombinant adeno-associated virus vector for Alzheimer's disease.
    Hara H; Monsonego A; Yuasa K; Adachi K; Xiao X; Takeda S; Takahashi K; Weiner HL; Tabira T
    J Alzheimers Dis; 2004 Oct; 6(5):483-8. PubMed ID: 15505369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
    Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
    J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
    Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I
    J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease.
    Scannevin RH; Chollate S; Brennan MS; Snodgrass-Belt PA; Peng H; Xu L; Jung MY; Bussiere T; Arastu MF; Talreja T; Xin Z; Dunstan RW; Fahrer D; Rohde E; Dunah AW; Wang J; Kumaravel G; Taveras AG; Moore Arnold H; Rhodes KJ
    Neuropharmacology; 2016 Apr; 103():57-68. PubMed ID: 26690893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active immunization with the peptide epitope vaccine Aβ3-10-KLH induces a Th2-polarized anti-Aβ antibody response and decreases amyloid plaques in APP/PS1 transgenic mice.
    Ding L; Meng Y; Zhang HY; Yin WC; Yan Y; Cao YP
    Neurosci Lett; 2016 Nov; 634():1-6. PubMed ID: 27693663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral amyloid β(42) deposits and microvascular pathology in ageing baboons.
    Ndung'u M; Härtig W; Wegner F; Mwenda JM; Low RW; Akinyemi RO; Kalaria RN
    Neuropathol Appl Neurobiol; 2012 Aug; 38(5):487-99. PubMed ID: 22126319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease?
    Lemere CA; Oh J; Stanish HA; Peng Y; Pepivani I; Fagan AM; Yamaguchi H; Westmoreland SV; Mansfield KG
    Rejuvenation Res; 2008 Apr; 11(2):321-32. PubMed ID: 18341428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus accelerates Aβ pathology in brain accompanied by enhanced GAβ generation in nonhuman primates.
    Okabayashi S; Shimozawa N; Yasutomi Y; Yanagisawa K; Kimura N
    PLoS One; 2015; 10(2):e0117362. PubMed ID: 25675436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
    Song Y; Kim HD; Lee MK; Hong IH; Won CK; Bai HW; Lee SS; Lee S; Chung BY; Cho JH
    PLoS One; 2017; 12(1):e0169509. PubMed ID: 28072821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plaque-bearing mice with reduced levels of oligomeric amyloid-beta assemblies have intact memory function.
    Lesné S; Kotilinek L; Ashe KH
    Neuroscience; 2008 Feb; 151(3):745-9. PubMed ID: 18155846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of Abeta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin.
    Haugabook SJ; Le T; Yager D; Zenk B; Healy BM; Eckman EA; Prada C; Younkin L; Murphy P; Pinnix I; Onstead L; Sambamurti K; Golde TE; Dickson D; Younkin SG; Eckman CB
    FASEB J; 2001 Jan; 15(1):16-18. PubMed ID: 11099491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebral Injection of Metal-Binding Domain of Aβ Comprising the Isomerized Asp7 Increases the Amyloid Burden in Transgenic Mice.
    Kulikova AA; Cheglakov IB; Kukharsky MS; Ovchinnikov RK; Kozin SA; Makarov AA
    Neurotox Res; 2016 May; 29(4):551-7. PubMed ID: 26842600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models.
    Zhao L; Gottesdiener AJ; Parmar M; Li M; Kaminsky SM; Chiuchiolo MJ; Sondhi D; Sullivan PM; Holtzman DM; Crystal RG; Paul SM
    Neurobiol Aging; 2016 Aug; 44():159-172. PubMed ID: 27318144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.